Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate vs Salpingostomy in Ectopic Pregnancy
NCT05136274Unknown
- Sponsor
- EDGREM Investimentos
- Start
- Aug 2021
- Primary completion
- Aug 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of methotrexate in Ectopic pregnancy (EP) (2 arms), sponsored by EDGREM Investimentos. Primary endpoint: Incidence of Ipsilateral tubal patency at 3 months. Status: unknown.
02
Drugs
methotrexate
03
Conditions
Ectopic pregnancy (EP)
Beyond the preview
Go deeper on NCT05136274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05136274.